0001171000-15-000112.txt : 20151124 0001171000-15-000112.hdr.sgml : 20151124 20151124161914 ACCESSION NUMBER: 0001171000-15-000112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151123 FILED AS OF DATE: 20151124 DATE AS OF CHANGE: 20151124 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nexvet Biopharma plc CENTRAL INDEX KEY: 0001618561 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 BUSINESS PHONE: 353 1 215 8100 MAIL ADDRESS: STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK STREET 2: RAHAN ROAD CITY: TULLAMORE , CO. OFFALY STATE: L2 ZIP: R35 FR98 FORMER COMPANY: FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd DATE OF NAME CHANGE: 20140903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farrell Geraldine T CENTRAL INDEX KEY: 0001632385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36828 FILM NUMBER: 151252943 MAIL ADDRESS: STREET 1: C/O NEXVET BIOPHARMA PLC STREET 2: NATL INST, FOSTERS AVENUE, MOUNT MERRION CITY: BLACKROCK STATE: L2 ZIP: 00000 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-11-23 0001618561 Nexvet Biopharma plc NVET 0001632385 Farrell Geraldine T C/O NEXVET BIOPHARMA PLC UNIT 5, SRAGH TECHNOLOGY PARK,RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 IRELAND 0 1 0 0 VP Operations, General Counsel Ordinary Shares 2015-11-23 4 M 0 4300 .125 A 21253 I By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> Ordinary Shares 4300 D Ordinary Shares 132 I By Nexvet EBT Limited Options to purchase shares .125 2015-11-23 4 M 0 4300 0 D 2019-07-01 Ordinary Shares 4300 5733 I By Geraldine Therese Farrell & Andrew John Benston <Bulla Bulla Family A/C> The reporting person and her spouse have shared voting and dispositive power with respect to these reported securities. The reporting person has sole voting and dispositive power over the reported securities pursuant to that certain Nominee Deed dated as of 11/14/14 by and between Nexvet EBT Limited and the persons named in the schedule thereto. Such Nominee Deed was executed in connection with the Issuer's November 2014 four-for-five share consolidation. 4,300 options to purchase shares vested and became exercisable on 11/19/15 after the Issuer's board of directors determined that there had been successful completion of an efficacy trial for an Issuer product. A further 2,867 options shall vest and become exercisable on 7/1/16, and 2,866 will vest on 7/1/17. /s/ Geraldine T. Farrell 2015-11-23